PRESS RELEASE published on 01/28/2026 at 07:30, 6 months 11 days ago 17% increase in revenue in 2025, strong acceleration expected in 2026 and financing for the business secured Fermentalg achieved a record revenue of €13.4 million in 2025, exceeding forecasts. New BioSolutions launched, aiming for €20 million revenue in 2026 and €50 million long term, with strong financial support from partner Huvepharma Partnership Financial Support Record Revenue FERMENTALG BioSolutions
BRIEF published on 01/27/2026 at 14:05, 6 months 12 days ago Fermentalg is organizing a video conference for investors Investors Revenue FERMENTALG Vidéo Conférence BioSolutions
BRIEF published on 01/23/2026 at 11:05, 6 months 16 days ago Fermentalg announces a video conference for its investors Investors Revenue FERMENTALG Vidéo Conférence BioSolutions
BRIEF published on 01/16/2026 at 18:05, 6 months 23 days ago Fermentalg unveils its financial agenda for 2026 Financial Results Euronext Growth FERMENTALG BioSolutions Financial Calendar 2026
BRIEF published on 01/16/2026 at 18:05, 6 months 23 days ago Fermentalg Announces 2026 Financial Agenda Financial Agenda FERMENTALG Aquatic Microorganisms 2026 Results BioSolutions
PRESS RELEASE published on 01/16/2026 at 18:00, 6 months 23 days ago 2026 Financial Agenda Fermentalg announces financial agenda for 2026, focusing on quarterly updates and sustainable BioSolutions from aquatic microorganisms Sustainable Development Financial Agenda ESG Ratings FERMENTALG Aquatic Microorganisms
BRIEF published on 01/16/2026 at 10:05, 6 months 23 days ago Fermentalg will hold a video conference for investors Investors FERMENTALG Vidéo Conférence Revenue 2025 BioSolutions
BRIEF published on 01/14/2026 at 18:05, 6 months 25 days ago Semi-annual review of Fermentalg's liquidity contract Liquidity Contract Transactions Shares 2025 FERMENTALG
BRIEF published on 01/05/2026 at 18:05, 7 months 3 days ago Summary of the number of voting rights and shares of Fermentalg Voting Rights AMF Financial Publication Fermentalg Actions Figures For 2025
BRIEF published on 12/03/2025 at 18:05, 8 months 5 days ago Fermentalg: Details on Share Capital and Voting Rights Share Capital Voting Rights AMF FERMENTALG BioSolutions
Published on 08/07/2026 at 23:15, 21 hours 16 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 21 hours 31 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 22 hours 1 minute ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 22 hours 16 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 4 hours 6 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 21 hours 10 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 1 hour ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 1 hour ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 2 hours ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 1 day 1 hour ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 1 hour ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 1 day 2 hours ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 12 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026
